$10.43
7.08% yesterday
NYSE, Aug 12, 10:00 pm CET
ISIN
NL0000200384
Symbol
CLB

Core Laboratories NV Stock price

$10.43
-2.01 16.16% 1M
-6.32 37.73% 6M
-6.88 39.75% YTD
-9.60 47.93% 1Y
-6.73 39.22% 3Y
-14.03 57.36% 5Y
-106.49 91.08% 10Y
-5.38 34.02% 20Y
NYSE, Closing price Tue, Aug 12 2025
+0.69 7.08%
ISIN
NL0000200384
Symbol
CLB
Sector

Key metrics

Basic
Market capitalization
$456.8m
Enterprise Value
$550.2m
Net debt
$93.4m
Cash
$31.2m
Shares outstanding
46.5m
Valuation (TTM | estimate)
P/E
15.7 | 12.6
P/S
0.9 | 0.9
EV/Sales
1.1 | 1.1
EV/FCF
14.0
P/B
1.8
Dividends
DPS
$0.04
Yield 1Y | 5Y
0.4% | 0.4%
Growth 1Y | 5Y
0.0% | -55.1%
Payout 1Y | 3Y
6.1% | 6.5%
Increased
0 Years
Financials (TTM | estimate)
Revenue
$517.4m | $517.4m
EBITDA
$71.3m | $71.3m
EBIT
$56.6m | $54.7m
Net Income
$29.6m | $36.1m
Free Cash Flow
$39.3m
Growth (TTM | estimate)
Revenue
0.7% | -1.2%
EBITDA
-2.8% | -5.9%
EBIT
-2.4% | -10.0%
Net Income
24.8% | 14.9%
Free Cash Flow
31.9%
Margin (TTM | estimate)
Gross
19.6%
EBITDA
13.8% | 13.8%
EBIT
10.9%
Net
5.7% | 7.0%
Free Cash Flow
7.6%
Financial Health
Equity Ratio
42.7%
Return on Equity
12.5%
ROCE
11.4%
ROIC
7.9%
Debt/Equity
0.5
More
EPS
$0.6
FCF per Share
$0.8
Short interest
44.7%
Employees
3k
Rev per Employee
$150.0k
Show more

Is Core Laboratories NV a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

Core Laboratories NV Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a Core Laboratories NV forecast:

1x Buy
9%
4x Hold
36%
6x Sell
55%

Analyst Opinions

11 Analysts have issued a Core Laboratories NV forecast:

Buy
9%
Hold
36%
Sell
55%

Financial data from Core Laboratories NV

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
517 517
1% 1%
100%
- Direct Costs 416 416
3% 3%
80%
101 101
6% 6%
20%
- Selling and Administrative Expenses 42 42
4% 4%
8%
- Research and Development Expense - -
-
-
71 71
3% 3%
14%
- Depreciation and Amortization 15 15
4% 4%
3%
EBIT (Operating Income) EBIT 57 57
2% 2%
11%
Net Profit 30 30
25% 25%
6%

In millions USD.

Don't miss a Thing! We will send you all news about Core Laboratories NV directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Core Laboratories NV Stock News

Positive
The Motley Fool
15 days ago
Core Laboratories (CLB 2.98%), a specialist in reservoir optimization and production enhancement services for the oil and gas industry, reported its second quarter 2025 earnings on July 23, 2025. GAAP revenue of $130.2 million for Q2 2025 outpaced analyst expectations of $129.1 million, and adjusted EPS of $0.19 matched consensus estimates.
Neutral
Seeking Alpha
19 days ago
Core Laboratories Inc. (NYSE:CLB ) Q2 2025 Earnings Conference Call July 24, 2025 8:30 AM ET Company Participants Christopher Scott Hill - Senior VP & CFO Gwendolyn Y. Gresham - Senior Vice President of Corporate Development & Investor Relations Lawrence V.
Neutral
PRNewsWire
20 days ago
REVENUE OF $130.2 MILLION, UP 5% SEQUENTIALLY AND FLAT YEAR-OVER-YEAR OPERATING INCOME OF $15.3 MILLION; EX-ITEMS, $14.5 MILLION, UP OVER 23% SEQUENTIALLY AND DOWN 11% YEAR-OVER-YEAR OPERATING MARGINS, EX-ITEMS, OF 11%, EXPANDED 160 BASIS POINTS SEQUENTIALLY, WITH INCREMENTAL MARGINS, EX-ITEMS, OF 41% GAAP EPS OF $0.22; EX-ITEMS, $0.19, UP 33% SEQUENTIALLY, AND DOWN 14% YEAR-OVER-YEAR COMPANY R...
More Core Laboratories NV News

Company Profile

Core Laboratories NV engages in the provision of proprietary and patented reservoir description, production enhancement, and reservoir management services to the oil and gas industry. It operates through the following business segments: Reservoir Description and Production Enhancement. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid, and gas samples and provides analytical and field services to characterize properties of crude oil and petroleum products. The Production Enhancement segment provides products and services relating to reservoir well completions, perforations, stimulations, and production. The company was founded in 1936 and is headquartered in Amsterdam, the Netherlands.

Head office Netherlands
CEO Lawrence Bruno
Employees 3,400
Founded 2012
Website www.corelab.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today